DK1100796T3 - Fremgangsmåde til fremstilling af en ikke-krystallinsk anhydratform af paroxetinhydrochlorid - Google Patents

Fremgangsmåde til fremstilling af en ikke-krystallinsk anhydratform af paroxetinhydrochlorid

Info

Publication number
DK1100796T3
DK1100796T3 DK99940290T DK99940290T DK1100796T3 DK 1100796 T3 DK1100796 T3 DK 1100796T3 DK 99940290 T DK99940290 T DK 99940290T DK 99940290 T DK99940290 T DK 99940290T DK 1100796 T3 DK1100796 T3 DK 1100796T3
Authority
DK
Denmark
Prior art keywords
preparing
paroxetine hydrochloride
anhydrate form
crystalline anhydrate
crystalline
Prior art date
Application number
DK99940290T
Other languages
Danish (da)
English (en)
Inventor
Victor Witold Jacewicz
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817196.0A external-priority patent/GB9817196D0/en
Priority claimed from GBGB9828777.4A external-priority patent/GB9828777D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1100796T3 publication Critical patent/DK1100796T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK99940290T 1998-08-07 1999-08-06 Fremgangsmåde til fremstilling af en ikke-krystallinsk anhydratform af paroxetinhydrochlorid DK1100796T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817196.0A GB9817196D0 (en) 1998-08-07 1998-08-07 Novel process
GBGB9828777.4A GB9828777D0 (en) 1998-12-29 1998-12-29 Novel compounds
PCT/GB1999/002592 WO2000008017A1 (en) 1998-08-07 1999-08-06 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride

Publications (1)

Publication Number Publication Date
DK1100796T3 true DK1100796T3 (da) 2003-08-25

Family

ID=26314179

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99940290T DK1100796T3 (da) 1998-08-07 1999-08-06 Fremgangsmåde til fremstilling af en ikke-krystallinsk anhydratform af paroxetinhydrochlorid

Country Status (24)

Country Link
EP (2) EP1100796B1 (bg)
JP (1) JP2002522434A (bg)
KR (1) KR20010072323A (bg)
CN (1) CN1321155A (bg)
AP (2) AP0102072A0 (bg)
AT (1) ATE239016T1 (bg)
AU (1) AU5428999A (bg)
BG (1) BG105310A (bg)
BR (1) BR9912858A (bg)
CA (1) CA2339857A1 (bg)
DE (1) DE69907467T2 (bg)
DK (1) DK1100796T3 (bg)
EA (1) EA200100221A1 (bg)
ES (1) ES2198940T3 (bg)
HK (1) HK1038230A1 (bg)
HU (1) HUP0105466A3 (bg)
ID (1) ID27914A (bg)
IL (1) IL141286A0 (bg)
NO (1) NO20010629L (bg)
PL (1) PL345885A1 (bg)
PT (1) PT1100796E (bg)
SK (1) SK1972001A3 (bg)
TR (1) TR200100444T2 (bg)
WO (1) WO2000008017A1 (bg)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69739561D1 (de) 1996-06-13 2009-10-15 Sumitomo Chemical Co Piperidin Derivative als Zwischenprodukte zur Herstellung von Paroxetine und Verfahren zu ihrer Herstellung
JP3796351B2 (ja) 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
AU2002224322A1 (en) * 2000-11-17 2002-05-27 Eli Lilly And Company Lactam dipeptide and its use in inhibiting beta-amyloid peptiderelease
US8697094B2 (en) 2002-10-16 2014-04-15 Takeda Pharmaceutical Company Limited Stable solid preparations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
NZ336587A (en) * 1997-01-15 2001-01-26 Smithkline Beecham P Spray dried paroxetine compositions using organic solvent selected from pyridine, acetic acid, acetonitrile, acetone, ethanol, propan-1-ol or tetrahydrofuran
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法

Also Published As

Publication number Publication date
AP2001002072A0 (en) 2001-03-31
PT1100796E (pt) 2003-09-30
BG105310A (bg) 2001-12-29
JP2002522434A (ja) 2002-07-23
DE69907467T2 (de) 2004-03-11
BR9912858A (pt) 2001-11-20
ATE239016T1 (de) 2003-05-15
AP0102072A0 (en) 2001-02-06
EP1100796A1 (en) 2001-05-23
NO20010629L (no) 2001-03-20
HK1038230A1 (en) 2002-03-08
KR20010072323A (ko) 2001-07-31
WO2000008017A1 (en) 2000-02-17
HUP0105466A3 (en) 2002-11-28
CA2339857A1 (en) 2000-02-17
HUP0105466A2 (hu) 2002-05-29
EA200100221A1 (ru) 2001-08-27
EP1321465A2 (en) 2003-06-25
SK1972001A3 (en) 2001-08-06
AU5428999A (en) 2000-02-28
TR200100444T2 (tr) 2001-07-23
NO20010629D0 (no) 2001-02-06
PL345885A1 (en) 2002-01-14
ID27914A (id) 2001-05-03
ES2198940T3 (es) 2004-02-01
IL141286A0 (en) 2002-03-10
EP1321465A3 (en) 2003-09-03
EP1100796B1 (en) 2003-05-02
CN1321155A (zh) 2001-11-07
DE69907467D1 (de) 2003-06-05

Similar Documents

Publication Publication Date Title
DK1253153T3 (da) Fremgangsmåde til fremstilling af 4"-substituerede-9-deoxo-9a-aza-9a-homoerythromycin-A-derivater
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
NO970939L (no) Fremgangsmåte ved fremstilling av paroksetinhydrokloridanhydrat
NO20071888L (no) Fremgangsmate for a syntetisere 4-aminosubstituerte forbindelser
FI20000564A0 (fi) Menetelmä nanolaminaattien valmistamiseksi
DK1255719T3 (da) Integreret fremgangsmåde til fremstilling af en alkenylsubstitueret aromatisk forbindelse
DK1309555T3 (da) Metode til fremstilling af amlodipinmaleat
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
NO20004261D0 (no) 2-aryletyl-(piperidin-4-ylmetyl)aminderivater som muscarin- reseptor antagonister
DK1065938T3 (da) Fremgangsmåde til fremstilling af et smøremateriale
DK1147712T3 (da) Fremgangsmåde til fremstilling af en mælkecalcium-sammensætning
DK1284268T3 (da) Fremstilling af en polymorf form af et thiazolidindionderivat
FR2832010B1 (fr) Procede de verification du comportement deterministe d'un reseau a commutation de paquet
DK1362040T3 (da) Fremgangsmåde til fremstilling af mesylater af piperidinderivater
DK1390330T3 (da) Integreret fremgangsmåde til fremstilling af alkyl- og alkenylsubstituerede aromatiske forbindelser
DK1100796T3 (da) Fremgangsmåde til fremstilling af en ikke-krystallinsk anhydratform af paroxetinhydrochlorid
DK1401816T3 (da) Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin
DK1049674T3 (da) Fremgangsmåde til fremstilling af (-) cis-3-hydroxy-1-methyl-4-(2,4,6-trimethoxyphenyl) -piperidin
DK1192134T3 (da) Fremgangsmåde til fremstilling af (R)-G(A)-(2,3-dimethoxyphenyl)-1-[2-(4-fluorphenyl)ethyl]-4-piperidinmethanol
DK1209980T3 (da) Fremgangsmåde til fremstilling af en kondenseret mælkeerstatning
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
NO324220B1 (no) Fremgangsmate for fremstilling av en polymorf
DK71397A (da) Fremgangsmåde til fremstilling af en strikvare
DK1113009T3 (da) Fremgangsmåde til fremstilling af sulfonylaminocarbonyltriazolinonsalte
DK1116443T3 (da) Fremgangsmåde til fremstilling af en fedtsammensætning